INTRODUCTION
============

The mammalian myocardium is composed of cardiomyocytes, which contain sarcomeres, the basic structural unit of muscle. Sarcomeres form a cohesive tissue-scale network of cell--cell adhesions at the intercalated disk (ICD) and cell--extracellular matrix adhesions at costameres in these cells. Embedded into the contractile network of cardiomyocytes is the nucleus, which is mechanically integrated into the cytoskeleton through nuclear envelope-spanning LINC (linker of nucleoskeleton and cytoskeleton) complexes, which consist of SUN domain proteins in the inner nuclear membrane and KASH domain proteins, Nesprins, or SYNEs in mammals, in the outer nuclear membrane ([@B9]). These complexes interface directly and indirectly with all components of the cytoskeleton on their cytoplasmic faces, and interact with the nuclear lamina on their nucleoplasmic faces ([@B9]). While it is well established that the formation and maintenance of cellular adhesions is dependent on proper cytoskeletal function (reviewed in [@B82]), our previous work (and that of others) implicates LINC complexes and the nuclear lamina as unexpected regulators of cellular adhesions at the plasma membrane ([@B66]; [@B23]; [@B86]). In addition to their structural roles, adhesions and components of the sarcomere are mechanoresponsive and play an important role in the biochemical signaling processes that promote cardiac function, such as the normal hypertrophic growth that occurs during cardiac development (reviewed in [@B62]; [@B58]). Thus, it is not surprising that defects in adhesion are strongly implicated in human cardiomyopathies ([@B83]; [@B17]; [@B36]).

The LINC complex and other components of the nuclear lamina, such as emerin and A-type lamins, are also genetically linked to various human myopathies, including dilated cardiomyopathy, arrhythmogenic cardiomyopathy, and syndromes with cardiac involvement such as Emery--Dreifuss muscular dystrophy (EDMD; [@B74]; [@B88]). Strikingly, a large proportion of individuals with dilated cardiomyopathies exhibit lamin A/C point mutations, preceded in prevalence only by mutations in titin ([@B1]; [@B6]). Point mutations in *Sun2*, one of the most widely expressed genes encoding a SUN domain--containing protein in mammals, have been found to act as genetic modifiers of cardiomyopathy, for example, exacerbating the severity of the disease in patients with mutations in the sarcomere component myosin binding protein C or other components of the nuclear lamina ([@B63]). These point mutations in *Sun2* reside either in the lamin A-binding region (M50T) or in the coiled-coil region, required for the trimerization of LINC complexes and Nesprin engagement (V378I; [@B85]; [@B63]). Further, SUN2 V378I and other point mutations in the coiled-coil region have been found in patients with EDMD or cardiomyopathy symptoms ([@B63]). Despite the strong association between disruption of the LINC complex or nuclear lamina and human cardiac disease, a mechanistic understanding of the origin of these genetic diseases remains elusive. One prevailing model focuses on characteristic changes in nuclear morphology that accompany disruption of nuclear lamina components ([@B66]; [@B27]; [@B99]), suggesting that nuclear fragility is the driving force behind disease etiology (reviewed in [@B16]).

An additional (or alternative) mechanistic link has recently come to light from studies employing mouse models of lamin depletion (or a cardiomyopathy-linked lamin A/C mutation, H222P). Here, several studies have uncovered altered MAP kinase and AKT signaling as a driver of cardiac dysfunction ([@B67], [@B69]; [@B96]; [@B11]); reversing this biochemical cascade by treatment with the TOR inhibitor rapamycin improved heart function ([@B11]; [@B52]). However, the mechanism(s) by which mutations in lamin A (or loss of lamin A) alter the AKT and TOR pathways remains unknown. Importantly, both the AKT and the profibrotic TGFβ pathways that drive cardiac hypertrophy and interstitial fibrosis are mechanoresponsive, largely through pathways sensitive to inputs from cellular adhesions and/or the state of the actomyosin cytoskeleton ([@B34]; [@B3]; [@B24]; [@B97]; [@B31]; [@B72]; [@B93]). Models of LINC complex ablation provide an opportunity to test whether communication of mechanical signals from the cytoskeleton to the nuclear interior ([@B44]; [@B49]; [@B28]; [@B87]; Luxton *et al.*, [@B56]; [@B20]; [@B37]; [@B54]; [@B70]; [@B86]) contributes to myocardium function, although to date this avenue of investigation has been largely unexplored.

Importantly, suppressing MAPK signaling improves cardiac performance in the lamin A/C H222P mouse model, significantly ameliorating the coincident fibrosis ([@B67], [@B68]; [@B96]; [@B11]). Moreover, fibrosis is a hallmark of the dysfunction characteristic of other laminopathic syndromes, including progeria and lipodystrophy ([@B73]; [@B48]). While the underlying mechanisms are poorly understood, it is interesting to note that MAN1, an integral inner nuclear membrane (INM) protein that requires A-type lamins to be retained at the INM ([@B75]), is a clear negative regulator of TGFβ signaling across a broad range of organisms ([@B77]; [@B53]; [@B35]). In addition to binding directly to R-SMADs, MAN1 has also been suggested to regulate SMAD signaling in a tissue stiffness-dependent manner ([@B8]).

Here, to address how LINC complexes contribute to heart function, we have examined the consequences of disrupting SUN2-­containing LINC complexes in the murine myocardium, and we find that this genetic perturbation induces cardiac hypertrophy. *Sun2-/-* mice display elevated AKT-mTOR and MAPK signaling in the myocardium, which we tie to increased integrin engagement at costameres. Surprisingly, these mice fail to induce expression of classic hypertrophy-associated genes, have a normal lifespan, lack fibrosis, and demonstrate down-regulation or unaltered levels of TGFβ target genes despite elevated levels of a transducer of this pathway, nuclear phospho-SMAD2. While lamin A/C is required for MAN1 targeting, we find that SUN2-null mice instead display elevated retention of MAN1 at the nuclear lamina. Taken together, these results suggest that A-type lamins and the LINC complex act in concert to regulate prohypertrophic signaling, but play antagonistic roles in driving fibrosis.

RESULTS
=======

Mice deficient for *Sun2* undergo cardiac hypertrophy
-----------------------------------------------------

To assess the functional consequences of *Sun2* loss in the murine myocardium, we obtained a previously reported *Sun2-/-* whole-body knockout mouse model ([@B50]). In wild-type (WT) left ventricular cardiomyocytes, SUN2 is localized to the nuclear envelope and is absent from *Sun2-/-* tissue (Supplemental Figure 1A); SUN1 expression is not substantially different in the hearts of *Sun2-/-* mice compared with WT (Supplemental Figure 1B). While we did not observe increases in spontaneous cardiac-associated deaths in aged mice (\>1 yr), gross histology of hearts cut at the midventricular level revealed enlargement of *Sun2-/-* hearts in comparison with WT hearts at more than 1 yr of age ([Figure 1](#F1){ref-type="fig"}A). These findings were recapitulated at the cellular level, as we observed significant enlargement of individual cardiomyocytes in the papillary muscle of *Sun2-/-* mice ([Figure 1](#F1){ref-type="fig"}, B and C). These results suggest that *Sun2-/-* mice exhibit age-­related cardiac hypertrophy at both the cellular and tissue levels.

![*Sun2-/-* murine hearts exhibit hypertrophy. (A) Paraffin-embedded hearts isolated from 13-mo-old WT and *Sun2-/-* mice were stained with Masson's trichrome. Representative images show enlargement of the *Sun2-/-* heart in comparison with the WT; images of additional hearts are displayed in Supplemental Figure 1C. (B) Paraffin-embedded hearts from WT and *Sun2-/-* mice were stained with antibodies against laminin to reveal cardiomyocyte outlines. Cardiomyocytes from left ventricular papillary muscle are shown in cross section. Note the enlargement of *Sun2-/-* cells as compared with WT. (C) Quantification of left ventricular papillary muscle cardiomyocyte cross-sectional area, showing a greater population of enlarged cells in *Sun2-/-* than in WT heart. *n* ≥ 86 cells (86--198 cells) for each of three mice per genotype. Error bars indicate SDs. Statistical significance determined by unpaired, two-tailed *t* test.](mbc-30-1664-g001){#F1}

*Sun2-/-* mice exhibit altered sarcomere structure and adhesion defects
-----------------------------------------------------------------------

Cardiac dysfunction is often tied to changes in sarcomere structure. In particular, myofibril disarray has been linked to sarcomere mutations, many of which drive increased contractile function of the sarcomere at the cellular level ([@B64]; [@B55]; [@B65]). Assessment of sarcomere organization in P50 mice by staining left ventricle (LV) cardiac tissue sections with phalloidin revealed the stereotypical banding of F-actin, corresponding to I-bands, in WT mice ([Figure 2](#F2){ref-type="fig"}A). However, *Sun2-/-* tissue displayed actin bands of irregular width that did not align laterally between adjacent myofibrils, as well as regions with extensive actin disorganization ([Figure 2](#F2){ref-type="fig"}A, arrowheads). At higher magnification by transmission electron microscopy (TEM), we find that while many regions of the *Sun2-/-* tissue still exhibited grossly intact myofibril structure ([Figure 2](#F2){ref-type="fig"}B), these regions displayed misaligned and wavy Z-bands ([Figure 2](#F2){ref-type="fig"}B, red lines) and M-bands ([Figure 2](#F2){ref-type="fig"}B, arrowheads), loss of clearly defined I-bands ([Figure 2](#F2){ref-type="fig"}B, arrows) and H-zones ([Figure 2](#F2){ref-type="fig"}B, arrowheads), and reduced sarcomere length ([Figure 2](#F2){ref-type="fig"}C). Focal regions of severe myofibril disarray with complete loss of sarcomere structure were also observed in the *Sun2-/-* LV ([Figure 2](#F2){ref-type="fig"}B, bottom panels).

![Sarcomere organization is perturbed in P50 *Sun2-/-* mice. (A) Frozen P50 WT and *Sun2-/-* cardiac left ventricle tissue was sectioned and stained with phalloidin to label F-actin in I-bands. While I-bands are evenly registered in WT tissue, the regularity of this pattern is lost in *Sun2-/-*. Note the variability in width of I-bands, their loss of alignment and increased wavy appearance, and focal loss of sarcomere structure (arrowheads). (B) Transmission electron micrographs (TEMs) of P50 WT and *Sun2-/-* left ventricle tissue. Classical sarcomere structure can be observed in WT mice, while *Sun2-/-* tissue exhibits misaligned and wavy Z-bands (compare red lines in WT vs. *Sun2-/-*) and loss of clearly defined I-bands (arrows). Focal regions of complete sarcomere disruption are also present in the *Sun2-/* tissue (bottom two panels). (C) Sarcomere length, as measured from Z-band to Z-band, is reduced in P50 *Sun2-/-* tissue. *n* = 3 mice for each genotype. Statistical significance determined by unpaired, two-tailed *t* test.](mbc-30-1664-g002){#F2}

Our previous work showing a requirement for SUN2 LINC complexes in intercellular adhesion organization and function ([@B86]) inspired us to examine the structure of intercalated discs, the intercellular adhesions that connect adjacent cardiomyocytes. TEM analysis revealed discontinuous jagged intercalated discs with lacunae where sarcomeric cytoskeletal filaments failed to properly interface with intercalated disk components in P50 *Sun2-/-* tissue (Supplemental Figure 2A, arrows). Further, we observed reduced electron density along the intercalated disk membranes, suggesting that there was reduced adhesion protein accumulation at these sites (Supplemental Figure 2A, arrowheads). Immunofluorescence staining of intercalated disk components desmoplakin I/II, corresponding to desmosomes, and β-catenin, corresponding to adherens junctions, revealed discrete bands that ran perpendicular to the cardiomyocyte lateral membranes in WT tissue (Supplemental Figure 2, B and C). However, we frequently observed expansion of these normally discrete bands into several thinner, separated bands in the *Sun2-/-* tissue (Supplemental Figure 2, B and C, arrowheads), which mirrored the discontinuous appearance of the intercalated discs at the level of TEM (Supplemental Figure 2A). These results suggest that intercellular adhesion is structurally perturbed in the absence of SUN2 LINC complexes.

Sarcomere disorganization precedes changes in nuclear morphology in *Sun2-/-* mice
----------------------------------------------------------------------------------

By P50 we observed extensive changes in sarcomere organization and cardiomyocyte adhesion in *Sun2-/-* mice. To address the likely foundational defect that drives these phenotypes, we next investigated early time points in mouse development. Further, as we observed altered nuclear morphology in P50 *Sun2-/-* cardiac tissue ([Figure 3](#F3){ref-type="fig"}, A and C), which has been suggested to drive disease in laminopathies and nuclear envelopathies ([@B66]; [@B27]; [@B99]), we also wished to investigate whether changes in the myocardium ultrastructure preceded or followed changes in nuclear shape. Morphological changes in nuclear shape were not present at P4 ([Figure 3](#F3){ref-type="fig"}, B and C), suggesting that defects in nuclear morphology arise only after mature cardiac beating begins. We did observe that P4 *Sun2-/-* nuclei exhibited a somewhat rounder morphology than the more elongated WT nuclei ([Figure 3](#F3){ref-type="fig"}B); however, we would argue that this observation likely reflects LINC complex-dependent tension normally being exerted by the cytoskeleton on the nucleus in WT cardiomyocytes, a phenomenon that may be lost upon ablation of LINC complexes ([@B99]; [@B29]).

![Nuclear morphology is normal at P4 but sarcomere organization is disrupted in *Sun2-/-* mice. (A--C) TEM of WT and *Sun2-/-* left ventricle tissue at P50 and P4. (A) At P50, nuclei in *Sun2-/-* tissue exhibit severe distortions of the nuclear envelope. (B) At P4, *Sun2-/-* nuclear envelope morphology is comparable to the morphology in WT tissue. Left panels display lower-magnification fields, illustrating the prevalence of morphologically similar nuclei in WT and *Sun2-/-* tissue. However, WT nuclei are more elongated than *Sun2-/-* nuclei. Right panels display higher magnification of single nuclei, highlighting the similarity in nuclear envelope structure in the two genotypes. (C) Insets from white boxed regions in A and B, illustrating the normal nuclear morphology at P4 and disruption by P50 in *Sun2-/-* tissue. (D) Frozen P4 WT and *Sun2-/-* cardiac left ventricle tissue was sectioned and stained with phalloidin. While nascent myofibrils in WT tissue display irregularity in I-band width and alignment, focal regions of *Sun2-/-* tissue exhibit severe sarcomere disruption (arrows). (E) TEM of P4 WT and *Sun2-/-* left ventricle tissue. Sarcomere structure is disrupted in *Sun2-/-* tissue, with cytoskeletal disorganization (arrowhead) and hypercontraction (arrow) visible in adjacent cells. Hypercontractile cells are outlined in white, while adjacent cells with more subtly disrupted sarcomere organization are outlined in red.](mbc-30-1664-g003){#F3}

Given that the nuclei appeared intact in the *Sun2-/-* LV at P4, we next asked whether the P50 sarcomere defects ([Figure 2](#F2){ref-type="fig"}) manifest before or after this stage in development; in addition, the ICDs are not yet mature at P4 ([@B32]; [@B94]), further allowing us to examine whether the sarcomere changes occurred before ICD formation. As many structures in the murine heart, including myofibrils and adhesions, continue to develop postnatally ([@B32]; [@B94]), phalloidin staining of P4 WT cardiac tissue revealed a less regular pattern of actin-rich I-bands than was observed at P50 ([Figure 3](#F3){ref-type="fig"}D vs. [Figure 2](#F2){ref-type="fig"}A). However, at this earlier age we again observed extensive disruptions in myofibril organization in *Sun2-/-* tissue in comparison with WT tissue ([Figure 3](#F3){ref-type="fig"}D, arrows). These defects were further clarified following TEM of P4 LV myocardium, where *Sun2-/-* tissue featured ragged sarcomeres with a loss of clearly discernible I-bands ([Figure 3](#F3){ref-type="fig"}E, arrowhead) and irregular Z-band spacing ([Figure 3](#F3){ref-type="fig"}E, arrow). This indicates that sarcomere disarray is present during early postnatal cardiac development in mice lacking *Sun2*, before changes in nuclear morphology and ICD maturation.

We identified several regions in the P4 *Sun2-/-* tissue with extensive, striking reductions in the spacing between Z-bands, a phenotype previously linked to hypercontractility of the sarcomere ([@B47]; [Figure 3](#F3){ref-type="fig"}E, arrow). It appears that this effect was cell-autonomous, as individual cells with this hallmark of hypercontractility were located only sporadically through the examined tissue, while adjacent cells displayed more subtle changes in sarcomere structure ([Figure 3](#F3){ref-type="fig"}E; compare cells outlined in white with adjacent cells outlined in red). In contrast to the P50 time point, we did not observe noticeable differences in intercellular adhesion in *Sun2-/-* mice during the 2-wk postnatal period when intercalated disk maturation occurred ([@B32]; [@B94]; Supplemental Figure 2D). This suggests that the sarcomere disarray in *Sun2-/-* mice precedes the alterations in intercellular adhesion, and that the intercalated disk defects observed by P50 may be a consequence of altered contractility and/or the sarcomere defects in these mice.

*Sun2-/-* mice exhibit increased integrin engagement and AKT/MAPK signaling
---------------------------------------------------------------------------

Given the established roles that costameres, the sites of cell--extracellular matrix adhesion, play in cardiac development, sarcomere organization, and integrin signaling upstream of the prohypertrophic AKT, mTOR, and MAPK pathways and their mechanoresponsive nature ([@B57]; [@B21]; [@B46]; [@B3]; [@B5]; [@B18]; [@B42]; [@B61]; [@B36]; [@B95]), we next examined costameres for functional changes in *Sun2-/-* mice. We employed a well-established antibody (9EG7) that recognizes a ligand-bound epitope of β1-integrin, thought to correspond to the active, engaged form of the protein ([@B51]; [@B4]; [@B89]). While levels of total β1-integrin were similar in WT and *Sun2-/-* P50 tissue, the levels of active 9EG7 β1-integrin appeared substantially higher in the *Sun2-/-* tissue ([Figure 4](#F4){ref-type="fig"}A; see additional examples in Supplemental Figure 2E). We did not observe an increase in active β1-integrin levels at P13 (Supplemental Figure 2F) or in 13-mo-old mice (Supplemental Figure 2G). These results suggest that integrin function at the costamere may be altered in the absence of SUN2 LINC complexes at a specific stage in murine cardiac development.

![*Sun2-/-* hearts display increased integrin engagement and AKT/MAPK signaling. (A) Frozen P50 WT and *Sun2-/-* cardiac left ventricle tissue was sectioned and stained with antibodies against total β1-integrin (top panels) or against the ligand-bound, active β1-integrin (9EG7) conformational epitope (bottom panels). Images were pseudocolored to depict the relative fluorescence intensity of the β1-integrin signal, with lighter colors indicative of higher intensity and darker colors indicative of lower intensity. Note the increased intensity of active β1-integrin in the *Sun2-/-* tissue. Images are representative of results for 3 mice per genotype (also see Supplemental Figure 2, E--G). (B--E) Representative immunoblots of ventricular lysate from three WT and three *Sun2-/-* mice at P50 or five WT and four *Sun2-/-* mice at 13 mo. Ponceau staining of total protein reveals even loading of samples. Plots to the right represent quantitative analysis from additional mice, represented as the mean ± SD for more than three WT or *Sun2-/-* mice. Full blots, used for quantifications, are shown in Supplemental Figure 3. For quantification, data are shown as a ratio of *Sun2-/-* to WT for the phosphorylated protein and total protein, expressed as a ratio. (B) Lysates from P50 mice were subjected to SDS--PAGE and immunoblotting with antibodies against phosphorylated AKT (pAKT), AKT, phosphorylated S6 (pS6), or S6, revealing elevated levels of pAKT in *Sun2-/-* tissue. Data are represented as the mean ± SD for three WT or *Sun2-/-* mice. (C) Lysates from P50 mice were subjected to SDS--PAGE and immunoblotting with antibodies against pERK1/2 and ERK2, revealing elevated levels of pERK1/2 in *Sun2-/-* tissue. Data are represented as the mean ± SD for three WT or *Sun2-/-* mice. (D) Lysates from 13-mo-old mice were subjected to SDS--PAGE and immunoblotting with antibodies against phosphorylated S6 (pS6), S6, phosphorylated AKT (pAKT), or AKT, revealing elevated levels of pS6 but similar levels of pAKT in *Sun2-/-* tissue vs. WT tissue. Data are represented as the mean ± SD for five WT or four *Sun2-/-* mice. (E) Lysates from 13-mo-old mice were subjected to SDS--PAGE and immunoblotting with antibodies against pERK1/2 and ERK2, revealing similar levels of pERK1/2 in *Sun2-/-* and WT tissues. Data are represented as the mean ± SD for three WT or *Sun2-/-* mice.](mbc-30-1664-g004){#F4}

Hypertrophy can be driven by integrin signaling, including through the AKT and MAPK pathways ([@B57]; [@B21]; [@B46]; [@B41]; [@B80]; [@B14]; [@B84]; [@B7]; [@B58]). Moreover, AKT activation has been linked to increased cardiac function and cardiomyocyte contractility ([@B41]; [@B80]; [@B14]; [@B7]). At the time point where we observe greater integrin engagement (P50), immunoblot analysis of WT and *Sun2-/-* myocardium reveals increased levels of phosphorylated AKT ([Figure 4](#F4){ref-type="fig"}B) and phosphorylated ERK1/2 ([Figure 4](#F4){ref-type="fig"}C) in *Sun2-/-* animals. Further, in hypertrophic 13-mo-old *Sun2-/-* mice we observed a dramatic increase in the level of phosphorylated ribosomal protein S6 ([Figure 4](#F4){ref-type="fig"}D), a key target downstream of the AKT and mTOR pathways linked to the hypertrophic response ([@B84]; [@B58]). At this 13-mo time point, where *Sun2-/-* mice no longer display increased integrin engagement (Supplemental Figure 2G), we failed to observe a significant increase in AKT phosphorylation ([Figure 4](#F4){ref-type="fig"}D) or pERK1/2 levels ([Figure 4](#F4){ref-type="fig"}E).

Loss of SUN2 uncouples AKT- and MAPK-driven hypertrophy from cardiac fibrosis
-----------------------------------------------------------------------------

In the vast majority of disease contexts, cardiac hypertrophy occurs coincident with interstitial fibrosis ([@B33]), including in the laminopathic mouse models ([@B67], [@B69]; [@B96]; [@B11]). Importantly, the consequences of disrupting lamin A function are quite severe, leading to death even before maturity is reached in the case of the lamin A/C-null model. Given the myriad cytological defects apparent in the myocardium of *Sun2-/-* mice, the gains in AKT and MAPK signaling, and cardiac hypertrophy, we were surprised that we failed to observe early death in the SUN2-null model. Remarkably, we found no increase in interstitial fibrosis in 13-mo-old *Sun2-/-* mice, as assessed by Masson's trichrome staining of collagen and quantification with a color-based pixel count algorithm ([Figure 5](#F5){ref-type="fig"}, A and B; see *Materials and Methods*). Moreover, pathological cardiac hypertrophy associated with fibrosis is typically accompanied by increased transcription of a number of fetal program genes involved in sarcomerogenesis, including involvement in the lamin A/C H222P mouse model ([@B40]; [@B90]). However, quantitative PCR (qPCR) revealed no significant increases in the expression of ANP, BNP, skeletal α-actin, or Serca2 in *Sun2-/-* mice in comparison with WT mice ([Figure 5](#F5){ref-type="fig"}C), suggesting that loss of SUN2 drives hallmarks of physiological rather than pathological hypertrophy (reviewed in [@B58]). We next assessed the levels of gene targets of TGFβ, which is a master regulator of profibrotic signaling, at both P50 and at 13 mo. At P50 we observed a consistent down-regulation of TGFβ-associated profibrotic genes, including fibronectin (FN1) and the collagen genes COL1A1 and COL3A1 ([Figure 5](#F5){ref-type="fig"}D). This does not appear to reflect a genomewide effect on the transcriptome, as a subset of TGFβ targets (FLNA) and nontargets (DES, which encodes Desmin) were unaltered ([Figure 5](#F5){ref-type="fig"}D). At 13 mo, levels of the FN1 and COL1A1 transcripts were similar between WT and *Sun2-/-* mice ([Figure 5](#F5){ref-type="fig"}E), consistent with the lack of fibrosis indicated by trichome staining ([Figure 5](#F5){ref-type="fig"}, A and B), although we note that COL3A1 levels are significantly up-regulated in mice lacking SUN2.

![*Sun2-/-* hearts do not exhibit fibrosis and show reduced or unaltered expression of TGFβ target genes. (A) Images of trichrome-stained WT and *Sun2-/-* hearts are insets taken from [Figure 1](#F1){ref-type="fig"}A. *Sun2-/-* tissue exhibits levels of collagen-positive staining (blue) equivalent to those in WT tissue surrounding blood vessels (top panels) and at interstitial sites (bottom panels). (B) Quantification of collagen-staining positiveness (the ratio of the number of blue pixels to total pixels; see *Materials and Methods*) in interstitial sites, showing equivalent levels of interstitial fibrosis in WT and *Sun2-/-* tissue. Unpaired, two-tailed *t* test failed to determine any difference to be significant. (C) qPCR analysis of ANP, BNP, skeletal α-actin, and Serca2 mRNA levels from 13-mo-old left ventricular total RNA. WT and *Sun2-/-* Ct values were normalized to GAPDH. Fold change of *Sun2-/-* mRNA levels was determined by calculating the 2^ΔΔCt^ after taking the mean of WT ΔCt values from five mice. *n* = 4 *Sun2-/-* mice. Lack of statistical significance as determined by unpaired, two-tailed *t* test. (D) qPCR analysis of FN1 (fibronectin), COL1A1 (collagen type I), COL3A1 (collage type III), POSTN (periostin), LTBP2 (latent TGFβ-binding protein 2), LOXL1 (lysyl oxidase homologue 1), FLNA (filamin A), and DES (desmin) in P50 left ventricular total RNA, revealing similar or reduced levels of TGFβ transcriptional targets in *Sun2-/-* mice. WT and *Sun2-/-* Ct values were normalized to PPIA. Fold change of *Sun2-/-* mRNA levels was determined by calculating the 2^ΔΔCt^ after taking the mean of WT ΔCt values from *n* = 2 WT or *Sun2-/-* mice. Statistical significance determined by one-way ANOVA followed by Dunnett's multiple comparisons test. P values are indicated in the graph. (E) qPCR analysis of left ventricular total RNA from 13-mo-old animals as described in D.](mbc-30-1664-g005){#F5}

Disrupted TGFβ signaling and increased retention of MAN1 at the nuclear envelope in SUN2-null mice
--------------------------------------------------------------------------------------------------

One of the major signaling pathways known to drive fibrosis in the heart is the TGFβ/SMAD cascade ([@B60]; [@B59]; [@B92]). To determine the point at which the TGFβ signaling cascade ([@B60]; [@B59]; [@B92]) is disrupted in the absence of SUN2, we performed immunofluorescence on P4 WT and *Sun2-/-* cardiac sections using antibodies against phosphorylated SMAD2 (pSMAD2; [Figure 6](#F6){ref-type="fig"}, A and B). Surprisingly, *Sun2-/-* cardiac tissue exhibited a striking increase in the nuclear localization of pSMAD2 in comparison to WT tissue ([Figure 6](#F6){ref-type="fig"}, A and B). These results raise the possibility that while the cytoplasmic aspects of TGFβ/SMAD signaling are increased in *Sun2-/-* cardiomyocytes, driving nuclear accumulation of pSMAD2, the nuclear aspects (transcription) are strongly abrogated in the absence of SUN2.

![MAN1 levels at the nuclear envelope are increased in the *Sun2-/-* myocardium. (A) *Sun2-/-* tissue exhibits qualitatively increased pSMAD2 nuclear localization. Frozen P4 WT and *Sun2-/-* cardiac left ventricle tissue was sectioned and stained with antibodies against pSMAD2 (gray) and counterstained with Hoechst 33342 (blue). Scale bar = 20 µm. (B) Enhanced pSMAD2 nuclear:cytoplasmic (N/C) ratio in *Sun2-/-* tissue. The relative maximum fluorescence intensity of the nuclear signal divided by the cytoplasmic signal for pSMAD2 in images obtained as in A. *n* = 503 cells for WT and *n* = 545 cells for *Sun2-/-*. Statistical significance determined by unpaired *t* test with Welch's correction. (C) Lysates from WT and *Sun2-/-* P50 mice were subjected to SDS--PAGE and immunoblotting with antibodies against MAN1 and GAPDH (as a loading control). (D) Quantification of densitometry analysis for MAN1 normalized to GAPDH. Data are represented as the mean ± SD for four WT or *Sun2-/-* mice. (E) Representative fluorescence micrographs of MAN1 staining in frozen sections of the P4 myocardium from WT or *Sun2-/-* mice. (F) Peak fluorescence intensity of MAN1 at the nuclear envelope determined by line scan with local background subtraction. Plotted with the SD (*n* \> 50 nuclei). Statistical significance determined by unpaired *t* test with Welch's correction.](mbc-30-1664-g006){#F6}

As MAN1 is established to be both a lamin A/C-binding protein and a nuclear-­localized negative regulator of TGFβ, we next examined the levels and localization of MAN1 in the myocardium of *Sun2-/-* mice. AT P50, we found that total protein levels of MAN1 were moderately higher in *Sun2-/-* mice, as detected by immunoblotting ([Figure 6](#F6){ref-type="fig"}, C and D). Further, in the myocardium of SUN2-null mice, we observed elevated levels of MAN1 by immunohistochemistry and quantitative analysis of fluorescence intensity across line profiles spanning the nuclear envelope ([Figure 6](#F6){ref-type="fig"}, E and F). Thus, while upstream events that drive profibrotic pathways are likely stimulated in the absence of SUN2, mechanical signaling through the LINC complex may be required for nuclear pSMAD2 to act on its target genes, potentially by driving release of MAN1 from the nuclear lamina.

DISCUSSION
==========

Here we demonstrate that a mouse model of SUN2 ablation develops cardiac hypertrophy, similarly to existing mouse models of A-type lamin dysfunction. Surprisingly, we observe that the SUN2-null mouse, unlike laminopathic mouse models, is protected from the involvement of interstitial fibrosis, suggesting that although the progrowth and profibrotic pathways may be driven by the same upstream factors, these two outcomes can be genetically uncoupled, potentially through distinct impacts on the targeting of MAN1 to the nuclear lamina. These findings raise the exciting possibility that future studies will reveal how modulating the nuclear lamina can be leveraged to disrupt tissue fibrosis.

The earliest effects of SUN2 ablation on cardiac muscle manifest during development, consistent with the recent observation that the LINC complex nucleates developing sarcomeres at the nuclear envelope and promotes the maintenance of myofibril structure in *Drosophila* lateral transverse muscle ([@B2]), as well as the observation that overexpression of human Nesprin-1α~2~ in a zebrafish model leads to defects in cardiac development ([@B98]). Although we cannot rule out a direct role for LINC complexes in organized sarcomere assembly during the development of mammalian cardiac muscle, we favor a model in which altered regulation of the contractile-adhesion network underlies the observed sarcomere defects both early and late in life in *Sun2-/-* mice. Indeed, integrin-based adhesions at costameres play essential roles in patterning the sarcomere during cardiac myofibrillogenesis ([@B79]; [@B15]; [@B32]; [@B19]). Such a model is consistent with our previous demonstration that the LINC complex can influence cell junctions ([@B86]) and the apparent increase in the levels of β1-integrin in its active, ligand-bound conformation in *Sun2-/-* cardiac tissue ([Figure 4](#F4){ref-type="fig"}A).

Further support for a potential foundational effect of increased contractility comes from our TEM analysis, which reveals that cardiomyocytes manifest with sarcomere defects reminiscent of those tied to hypercontractility ([@B47]) shortly after birth. Interestingly, a small molecular inhibitor of sarcomere power output in cardiomyocytes can be protective in an HCM model, suggesting that increased cardiomyocyte contractility can drive cardiac hypertrophy ([@B26]). Thus, altered contractile properties of *Sun2-/-* cardiomyocytes could drive the LV hypertrophy we observe. How could SUN2 LINC complexes influence sarcomere contractile function? Beyond its direct interactions with the actin cytoskeleton, the LINC complex is implicated as a regulator of RhoA activity ([@B91]), interacts with other modulators of actin organization and function, such as the formin FHOD1 in fibroblasts ([@B43]), and is known to influence actin dynamics ([@B44]; [@B49]; [@B28]; [@B87]; [@B38]; Luxton *et al.*, 2010; [@B20]; [@B39]). However, it should be noted that while increased cardiac contractility at the organ level is frequently observed in HCM, cell autonomous hypercontractility is not always observed in these disease models ([@B65]). Recent work also suggests that the disease-associated D192G lamin A/C mutation may produce cytoskeletal and adhesion defects in neonatal rat cardiomyocytes ([@B45]), while a human cardiomyopathy patient with the point mutation G382V in *LMNA* exhibited defective plakoglobin localization to ICDs in the right ventricle ([@B76]). Whether cardiomyocytes in models of laminopathies exhibit altered adhesion function or contractile properties remains a critical future question.

Although it remains to be fully tested, we suggest that increased contractility in *Sun2-/-* mice could be responsible for the gain in β1-integrin engagement that we observe. Indeed, increased integrin activation can be driven by heightened intracellular actomyosin contractility, as has been shown for the integrin LFA-1 in migrating T-cells ([@B71]). Integrin engagement and subsequent activation of AKT signaling has also been shown to drive cardiac hypertrophy in mouse models (reviewed in [@B5]; [@B82]), and AKT activation is linked to elevated cardiomyocyte contractility ([@B41]; [@B80]; [@B14]; [@B7]), suggesting a potential connection between contractility, active β1-integrin levels, and hypertrophy in *Sun2-/-* mice. Consistent with this model, we observe heightened levels of phosphorylated AKT at P50 in *Sun2-/-* mice ([Figure 4](#F4){ref-type="fig"}B). Importantly, a similar transient AKT activation in adolescent mice followed by sustained AKT-mTOR downstream signaling has previously been described in the cardiac tissue of the lamin A/C H222P mutant mouse ([@B67], [@B68]a,[@B69]; [@B96]; [@B11]; [@B12]; [@B78]). The mechanisms by which loss of A-type lamin function leads to increased AKT and MAPK signaling, observed in numerous mouse models ([@B67], [@B68],[@B69]; [@B96]; [@B11]; [@B12]; [@B78]), has yet to be defined; our work suggests that further study of signaling from integrin-based adhesions may prove fruitful.

*LMNA-/-*, lamin A/C H222P, and the *Sun2-/-* mouse models all share an increase in SMAD2 phosphorylation and nuclear localization ([@B10]). In the context of lamin perturbation, this occurs coincident with the induction of TGFβ-associated gene expression and severe cardiac fibrosis ([@B10]). In contrast, *Sun2-/-* mice display hypertrophy without fibrosis, mimicking physiological hypertrophy, which is characterized by hypertrophy with a lack of fibrosis or reactivation of fetal program genes ([@B58]). This is similar to what is observed during cardiac growth compensation in response to exercise and pregnancy ([@B22]; [@B25]; [@B13]) or in models of AMP-insensitive "activated" AMPK mutations ([@B30]). One model is that SUN2 is a required component of a pathway that "licenses" nuclear pSMAD2 to act on its target genes. Our observation that MAN1 accumulates at the nuclear lamina in the absence of SUN2 suggests that its repression of TGFβ/SMAD signaling is alleviated in contexts where the LINC complex is under tension.

Importantly, treatment of mouse models of lamin dysfunction with the TOR inhibitor rapamycin influences heart function positively and ameliorates cardiac hypertrophy and fibrosis ([@B67], [@B68]a,[@B69]; [@B96]; [@B11]; [@B12]; [@B78]). As human laminopathy patients typically display left ventricular dilation coupled with fibrosis ([@B74]; [@B63]; [@B88]), identifying the mechanisms that drive profibrotic signaling remains a critical need. Further study of the nuclear aspect of this signaling cascade through modulating MAN1 may identify new approaches for intervening in pathological fibrosis.

MATERIALS AND METHODS
=====================

Mouse breeding and care
-----------------------

All animal care and experimental procedures were conducted in accord with requirements approved by the Institutional Animal Care and Use Committee of Yale University. *Sun2-/-* (strain B6;129S6-*Sun2^tm1Mhan^*/J) and C57BL/6 WT mice were obtained from Jackson ImmunoResearch Laboratories. *Sun2-/-* mice were previously generated through the replacement of exons 11--16 and part of exon 17 with a neomycin resistance cassette ([@B50]).

Mouse tissue isolation, histology, and immunofluorescence staining
------------------------------------------------------------------

### Cardiac isolation.

WT and *Sun2-/-* murine hearts were isolated from P4 or P45/P47/P50 mice and perfused with PBS, and left ventricular tissue was either frozen in O.C.T. compound (Sakura, Tissue-Tek) at -80°C for cryosectioning or fixed in 10% neutral buffered Formalin and embedded in paraffin in collaboration with the Yale University Developmental Histology Facility in the Department of Pathology. Frozen samples were sectioned using a cryostat (CM3050S; Leica). For histological analyses, 10-µm sections were cut and stained with hematoxylin and eosin. For immunofluorescence, 6- or 8-µm sections were fixed in 4% formaldehyde or 4% paraformaldehyde at RT for 10 min.

### Immunofluorescence staining.

For immunostaining with nonmouse primary antibodies, tissue sections were blocked in gelatin block (2.5% normal goat serum, 1% BSA, 2% gelatin, and 0.25% Triton X-100 in PBS) at RT for 1 h and incubated with the following primary antibodies overnight at 4°C: SUN2 (1:100; rabbit; Abcam ab124916), total β1-integrin (1:50; rat; Novus Biologicals NBP1-4323, clone KMI6), conformational epitope β1-integrin (1:50; rat; BD Pharmingen \#550531, clone 9EG7), paxillin (1:100; rabbit; Abcam ab32084, clone Y113), or phosphorylated SMAD2 (1:100, rabbit, Cell Signaling \#8828, clone D27F4). For immunostaining with the mouse primary antibodies desmoplakin I/II (1:50; mouse; Abcam ab16434, clone 2Q400), β-catenin (1:100; mouse; BD Transduction Labs \#610153), and anti-MAN1 antibody (BBMAN1A22,44; kind gift from Brian Burke and Martina Maric, Institute of Medical Biology, Singapore), the Mouse-on-Mouse (M.O.M.) Immunodetection Kit blocking reagent and protein diluent (Vector Laboratories) were used according to the manufacturer's instructions. Sections were subsequently washed in multiple changes of PBS and incubated with fluorescent dye--conjugated secondary antibodies (1:1000; mouse, rat, or rabbit; Alexa Fluor; Life Technologies) in gel block or M.O.M.-containing gel block when appropriate. Costaining with Hoechst 33342 (Thermo Fisher Scientific; 1:2000), Alexa Fluor 594-conjugated wheat germ agglutinin (Life Technologies; 1:2000), and/or Alexa Fluor 594-conjugated phalloidin (Invitrogen \#A12381; 1:40) was performed when indicated. Sections were mounted using Fluoromount-G mounting medium (SouthernBiotech).

Transmission electron microscopy
--------------------------------

TEM was performed in the Yale School of Medicine Center for Cellular and Molecular Imaging Electron Microscopy core facility. Left ventricular cardiac tissue from P4 and P45/P47 WT and Sun2-/- mice were isolated and processed for TEM; three mice were examined for each genotype at each time point. Tissue blocks were fixed in 2.5% glutaraldehyde/2% paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, for 30 min at room temperature (RT) and 1.5 h at 4°C. The samples were rinsed in sodium cacodylate buffer and were postfixed in 1% osmium tetroxide for 1 h. The samples were rinsed and stained en bloc in aqueous 2% uranyl acetate for 1 h, followed by rinsing, dehydrating in an ethanol series to 100%, rinsing in 100% propylene oxide, infiltrating with EMbed 812 (Electron Microscopy Sciences) resin, and baking overnight at 60°C. Hardened blocks were cut using an ultramicrotome (UltraCut UC7; Leica). Ultrathin 60-nm sections were collected and stained using 2% uranyl acetate and lead citrate for transmission microscopy. Carbon-coated grids were viewed on a transmission electron microscope (Tecnai BioTWIN; FEI) at 80 kV. Images were taken using a charge-coupled device (CCD) camera (Morada; Olympus) and iTEM (Olympus) software.

Imaging and image analysis
--------------------------

### Immunofluorescence imaging.

Whole slides of hematoxylin- and eosin-stained or trichrome-stained cardiac sections were scanned using an Aperio digital pathology scanner at 40× magnification in collaboration with Yale University Pathology Digital Imaging in the Department of Pathology. Cardiac sections processed for immunofluorescence were imaged on a Leica SP5 confocal microscope or a widefield deconvolution microscope (DeltaVision; Applied Precision/GE Healthcare) with a CCD camera (CoolSNAP K4; Photometrics) and SoftWoRx software. All images acquired on the DeltaVision microscope were deconvolved using the Deconvolve tool (constrained iterative deconvolution) in SoftWoRx software. The DeltaVision microscope was equipped with an oil Plan Apochromat N 60×/1.42 NA objective (Olympus). In all cases, images were analyzed using Fiji software (ImageJ 1.48d; National Institutes of Health) as indicated.

### Analysis of cardiomyocyte size.

Transverse midventricular sections of WT and *Sun2-/-* murine hearts were cut and stained with antibodies against laminin in collaboration with the Yale University Developmental Histology Facility in the Department of Pathology. The cross-sectional area of between 86 and 198 left ventricular papillary muscle cells was measured by manually outlining individual cells and using the measure tool in Fiji (ImageJ 1.51j; National Institutes of Health; [@B81]). All cells in a given field were measured and only fields with circular blood vessels---indicating that the adjacent cells were sectioned orthogonal to the plane---were included.

### Analysis of fibrosis.

Transverse midventricular sections of WT and *Sun2-/-* murine hearts were cut and stained with Masson's trichrome stain in collaboration with the Yale University Developmental Histology Facility in the Department of Pathology. Whole slides were scanned using an Aperio Digital Pathology Scanner at 40× magnification in collaboration with Yale University Pathology Digital Imaging in the Department of Pathology. The ImageScope 12.2 Positive Pixel Count algorithm (Aperio Technologies) was used to identify blue-colored collagen fibers in the tissue samples. Color hue and saturation values (hue value of 0.62, hue width of 0.40, and color saturation threshold of 0.005) were optimized before the analysis. Five or more fields of interstitial tissue were assessed for each of three mice per genotype.

### Analysis of sarcomere length.

TEM micrographs of P50 WT and *Sun2-/-* ventricular tissue were acquired as described. The sarcomere length, defined as the distance from the center of one Z-band to the center of a successive Z-band, was measured in Fiji for between 94 and 235 sarcomeres for three mice of each genotype. All sarcomeres with visible Z-bands in a given field were measured.

### Display of β1-integrin fluorescence intensity.

Images of WT and *Sun2-/-* ventricular tissue stained with antibodies against the ligand-bound β1-integrin conformation were acquired on the Leica SP5 microscope using the same acquisition settings between WT and *Sun2-/-* samples. WT and *Sun2-/-* images were scaled to one another and pseudocolored in Fiji using the Fire LUT, converting differences in pixel intensity to differences in display color; on this scale, lighter colors correspond to higher fluorescence intensity, while darker colors correspond to lower fluorescence intensity.

### pSMAD2 nuclear:cytoplasmic intensity ratio measurements.

Using images as in [Figure 6](#F6){ref-type="fig"}A, nuclei were segmented by thresholding the Hoechst signal, binarizing, and creating individual nuclear masks using the Analyze Particles function in ImageJ. The resulting masks were used to measure the nuclear pSMAD2 fluorescence intensity maxima following background subtraction. The masks were converted to a band of 1.5 pixels to measure perinuclear cytoplasmic intensity maxima. The nuclear:cytoplasmic intensity ratio was calculated as the nuclear intensity maximum divided by the cytoplasmic intensity maximum.

### MAN1 fluorescence intensity measurements.

Using images as in [Figure 6](#F6){ref-type="fig"}E, line profiles bisecting the nucleus of equal length were taken (\>50 per sample) in ImageJ. The local intensity maxima at the nuclear envelope after subtraction of the mean intensity across the entire line profile was then calculated.

Western blotting
----------------

Following heart isolation and PBS perfusion, ventricular cardiac tissue was isolated from 13-mo-old WT and *Sun2-/-* mice or P45/P47 WT and *Sun2-/-* mice, minced, and homogenized using a Polytron PT 1200 E homogenizer (Kinematica AG) in radioimmunoprecipitation lysis buffer (50 mM Tris-Cl, pH 7.4, 1 mM EDTA, 1% NP-40 alternative, 0.1% Na deoxycholate, 0.1% SDS, 150 mM NaCl, protease inhibitor cocktail \[Sigma-Aldrich\]). The insoluble debris was removed by centrifugation for 30 min at 14,000 rpm in a 4°C tabletop microcentrifuge (Sorvall Legend Micro 21R; Thermo Fisher Scientific). Extracted protein samples were diluted in SDS--PAGE sample buffer and separated using a 7.5% polyacrylamide gel. The separated proteins were transferred to a nitrocellulose membrane using a transfer system (Bio-Rad Laboratories) and subjected to Ponceau S (Sigma) staining to observe total protein loading. Membranes were subsequently blocked in 10% nonfat milk (Omniblok; American Bioanalytical) or, if being blotted with phospho-antibodies, 5% BSA (AmericanBio) in TBST (TBS with Tween 20) for 1 h at RT and incubated with AKT (1:1000, rabbit, Cell Signaling 9272), pAKT (1:1000, rabbit, Cell Signaling 4060 clone D9E), S6 (1:5000, rabbit, Cell Signaling 2217 clone5G10), pS6 (1:5000, rabbit, Cell Signaling 2211 Ser235/236), ERK2 (1:200, rabbit, Santa Cruz SC-154), pERK1/2 (1:300, mouse, Cell Signaling 9101 Thr202/204), and MAN1/LEMD3 (1:1000, rabbit, ProSci 6603) primary antibodies at 4°C overnight. The membranes were washed for 15 min in TBST and then incubated for 1 h with HRP-conjugated secondary antibodies (1:5000; Pierce Antibodies; Thermo Fisher Scientific) in TBST at RT. After washes with TBST, the membranes were incubated with HRP chemiluminescent substrate (SuperSignal West Femto Chemiluminescent Substrate; Thermo Fisher Scientific) for 5 min and then imaged using a VersaDoc imaging system (Bio-Rad Laboratories).

qPCR
----

Following heart isolation and PBS perfusion, ventricular cardiac tissue was isolated from 13-mo-old WT and *Sun2-/-* mice or P54/P55 WT and *Sun2-/-* mice, minced, and homogenized in TRIzol (Invitrogen). Total RNA was isolated using the RNeasy kit (QIAGEN) according to manufacturer's instructions. To remove genomic DNA, total RNA was digested with DNase I (Roche) according to manufacturer's instructions and repurified using the RNeasy kit (QIAGEN). To generate cDNA, equal amounts of digested total RNA (1 μg) were added to SuperScript III Reverse Transcriptase (Invitrogen) reactions using Random Primer 9 (New England Biolabs). Quantitative real-time PCR was conducted with a Bio-Rad CFX96 Real-Time System using the iQ SYBR Green Supermix (Bio-Rad) for 39 cycles. Primers used in these experiments were ANP forward: CAAGATGCAG­AAGCTGCTGG and reverse: GTGCTGCCTTGAGACCGAAGG; BNP forward: GTTTGGG­CTGTAACGCACTGA and reverse: GAAAGAGACCCAGGCAGA­GTCA; Skeletal α-actin forward: CATGAAGATCAAGATCATCGC and reverse: CTGGAAGGTGGACAGCGAGGC; Serca2 forward: GTGTGGCAGGAAAGAAATGC and reverse: CCAGGAACTATGTCTTTAGC; FN1 forward: TTCA­AGTGTGATCCCCATGAAG and reverse: CAGGTCTACGGCAGTTGTCA; COL1A1 forward: CTGGCGGTTCAGGT­CCAAT and reverse: TTCAGGCAATCCAGAGC; COL3A1 forward: CTGTAACATGG­AA­ACTGGGGAAA and ereverse: CCAT­AGCTGAACTGAAAACCACC; POSTN forward: CCTGCCCTTATATGCTCTGCT and reverse: AAACATGGTCAATAGGCATCACT; LTBP2 forward: GCTCACCGGGA­GAAATGTCTG and reverse: CAGGTTTGATACAGTGGTTGGT; LOXL1 forward: GAGTGCTATTGCGCTT­CCC and reverse: GGTTGCCGAAGTCACAGGT; FLNA forward: GGCTACGGTGGGCTTAGTC and reverse: GTGGGACAGTAGGTGACCCT; DES forward: TACACCTGCGAGATTGATGC and reverse: ACATCCAAGGCCATCTTCAC; GAPDH forward: CGTAGAC­AAAATGGTGAAG­GTCGG and reverse: AAGCAGTTGGTGGTGCAGGATG; and PPIA forward: GAGCTGTTTGCAGACAAAGTTC and reverse: CCCTGGCACATGAATCCTGG. PCR product levels were normalized to peptidylprolyl isomerase A (PPIA) or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA levels.
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